Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus butorphanol for burn dressing change sedation and analgesia
ChiCTR2000032691Phase 4Not yet recruiting
- Sponsor
- Jiangsu University Affiliated Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and butorphanol in burn injury (2 arms), sponsored by Jiangsu University Affiliated Hospital. Primary endpoints: VAS score, RSS score and 4 more. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR2000032691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032691.